InvestorsHub Logo
Followers 167
Posts 35823
Boards Moderated 4
Alias Born 10/20/2019

Re: Hitman970 post# 182898

Tuesday, 04/16/2024 2:42:30 PM

Tuesday, April 16, 2024 2:42:30 PM

Post# of 182924
$NBIO - Mr. Carrick continued, "Phase I demonstrated an excellent safety profile at various doses. Phase II will be focused on clinical outcomes, and we are taking no shortcuts."
https://finance.yahoo.com/news/nascent-prepares-pivotal-phase-ii-120000620.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.